This seminar will focus on strategies and techniques to maximize efficiency and resolution when using reversed phase chromatography (RPC) and size exclusion chromatography (SEC) in analyzing biomacromolecules. Aspects of method development and troubleshooting will be examined for both modes of chromatography.
At the conclusion of the seminar, the engaged attendee will learn:
- How to select and the importance of phase chemistry and particle morphology in analyzing biomolecules
- Best practices in choosing appropriate mobile phase systems for each mode of chromatography
- How to diagnose the source of problems when troubleshooting biomolecule separations
Analyzing biomacromolecules is a unique analytical challenge owing to a number of product-related impurities and the complexity of the analytes. This complexity is a result of the myriad number of modifications to these analytes in each sample including, but not limited to, phosphorylation, methylation, and glycosylation. Due to the heterogeneity of an individual analyte, in addition to a biomolecule’s tendency to interact with silica-based, reversed-phase stationary phases, the resulting chromatographic peak can exhibit extensive broadening and tailing. To further complicate matters, most large proteins do not ionize well using conventional electrospray ionization mass spectrometers. In addition, when a mixture of proteins is not well-resolved, chromatographically, prior to the mass spectrometer, further ion suppression can occur. At a higher level, sample heterogeneity also increases with aggregated and fragmented proteins. This is routinely determined by size exclusion chromatography, often lacking a deeper characterization of the impurities. Therefore, the need for highly efficient, robust, and reproducible analytical methods is not a suggestion, but a requirement, for accurate characterization of proteinaceous samples.
Speakers
Andrea Krumm
Tosoh Bioscience GmbH
Product Manager, Analytical Columns
Andrea Krumm studied biotechnology before gaining a PhD in Cell and Cancer Biology. After four years as an applications specialist for optical analytical devices used in academic and pharmaceutical research, she joined Tosoh Bioscience GmbH in 2020 as a product manager for analytical columns. Andrea is responsible for gathering customer requirements, application areas and addressing these with new and existing products of the analytical columns line.
Cory E. Muraco
Merck
Biomolecule Workflows Manager
Cory E. Muraco is the Biomolecule Workflows Manager at Merck KGaA, Darmstadt, Germany. After finishing his graduate studies at Youngstown State University (Youngstown, Ohio, USA), Cory started his career there in 2013. After holding several roles in both R&D and Marketing functions, in 2022, Cory assumed his current role as the Biomolecule Workflows Manager where he is tasked with designing, developing, and executing the marketing and R&D strategies around the company's bioanalytical initiative. Cory is the author of several manuscripts appearing in trade magazines and has delivered over 100 presentations at international conferences, round table symposia, and at various pharmaceutical and biopharmaceutical companies.
Analytical chemistry
- Large molecule HPLC
Dauer:1h
Sprache:English
Sitzung 1:vorgestellt October 18, 2022
Um weiterzulesen, melden Sie sich bitte an oder erstellen ein Konto.
Sie haben kein Konto?